Comparing the current results to its competitors, Intelligent Bio Solutions Inc reported Revenue increase in the 4 quarter 2026 by 35.78 % year on year. The sales growth was above Intelligent Bio Solutions Inc 's competitors' average revenue growth of 12.95 %, achieved in the same quarter.
Intelligent Bio Solutions Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 80.75 %
Intelligent Bio Solutions Inc 's Comment on Competition and Industry Peers
IFP has developed a Point of Care (POC) drug screening test system and a laboratory-based confirmation testing service that analyze fingerprint sweat samples. Traditional competitor POC and confirmation tests typically use urine or oral fluid (saliva) samples. The medical device industry is competitive and rapidly evolving, with potential competition from major medical device companies globally that have longer operating histories and greater resources. Key competitive factors include product performance, reliability, connectivity, manufacturing cost, and customer support. Competitors identified in filings include IFP and LSBD.
Strong sales growth of 35.78 % in Overall company contributed to Intelligent Bio Solutions Inc increase in total revenue by 35.78 % Intelligent Bio Solutions Inc improved its market share in this segment, to approximately 0.01 %.
October 23, 2025
Breaking New Ground: Intelligent Bio Solutions Gains Major Partnerships with Industry GiantsIntelligent Bio Solutions has recently secured a significant contract with a multinational industrial service provider in the UK, marking a pivotal moment for the company as it continues to expand its reach in Europe. The industrial giant, employing approximately 3,000 staff within the UK and Ireland, and over 30,000 employees globally, has opted to integrate Intelligent Bio Solutions innovative drug testing technology as part of its workplace safety and compliance measures.This contract further evidences Intelligent Bio Solutions’ groundbreaking approach in revolutionizing drug testing methodologies. Adding to th...
January 31, 2025
Intelligent Bio Solutions: Pioneering a Global Approach to Drug Screening In an era marked by rapid technological advancements and an increasingly interconnected world, Intelligent Bio Solutions Inc (INBS) is at the forefront of a movement that seeks to transcend linguistic barriers. Through its revolutionary upgrade, the INBS Drug Screening System is set to become a truly global tool, broadening its accessibility to an impressive four billion potential users across the Americas, Europe, Asia, and the Middle East. This groundbreaking development not only exemplifies INBS’s commitment to global expansion but also represents a strategic move in anticipation of its eagerly anticipated debut in the United Stat...
November 13, 2024
The Promises and Challenges of Intelligent Bio Solutions Fingerprint Sweat Drug Detection Technology The healthcare industry is continuously evolving, with innovative technologies emerging that promise to enhance drug detection methods. Recently, Intelligent Bio Solutions Inc. announced positive results from its pharmacokinetic (PK) study, marking a significant step towards FDA 510(k) submission. This study showcases the potential of utilizing fingerprint sweat as a reliable biological sample for drug detection a novel approach that could revolutionize how substances are screened in various settings, from workplace testing to clinical diagnostics. The key finding of the PK study is that fingerprint sweat ca...
October 1, 2024
Harnessing Innovative Drug Testing for Enhanced Maritime Safety: GPS Marine s Adoption of Intelligent Bio SolutionsIn the increasingly complex and critical field of maritime services, maintaining a drug-free workplace is essential for safety, efficiency, and reliability. In a groundbreaking move, GPS Marine, a prominent provider of marine construction and logistics services, has embraced cutting-edge technology to enhance its workplace safety measures. This article delves into how GPS Marine has integrated the Intelligent Bio Solutions (INBS) fingerprint drug testing technology into its operations, reflecting a notable shift towards advanced safety protocols in the maritime industry. GPS Marine: A Leader in...
September 5, 2024
In the rapidly advancing sphere of medical technology, the integration of intelligent, non-invasive testing solutions has opened new avenues for drug screening and monitoring. One company at the forefront of this innovation is Intelligent Bio Solutions Inc. (Nasdaq: INBS), which is diligently progressing towards the completion of a clinical study plan essential for its FDA 510(k) submission. This article delves into the company s recent initiatives, focusing on its pharmacokinetic (PK) study and the implications for the future of drug testing in the United States. Overview of Intelligent Bio Solutions Inc. Intelligent Bio Solutions Inc. specializes in the development of rapid, non-invasive testing solutions ...
July 24, 2024
Intelligent Bio Solutions Partners with QabasTech as Exclusive Distributor in Saudi Arabia Intelligent Bio Solutions Inc. (Nasdaq: INBS or the Company), a forward-thinking medical technology company specializing in intelligent, rapid, non-invasive testing solutions, has taken a significant step towards reinforcing its presence in Saudi Arabia. The company announced on July 24, 2024, that QabasTech (Qabas) will serve as its exclusive distributor in the region. This development underscores the strategic importance of Saudi Arabia for Intelligent Bio Solutions and aligns with the country s ambitious infrastructure projects and commitment to improving public safety. Partnership Details The agreement between In...
June 18, 2024
In a remarkable stride towards global expansion, Intelligent Bio Solutions has initiated subject dosing and sampling for its FDA 510(k) Pharmacokinetic (PK) Study. This landmark study aims to assess the performance and effectiveness of their groundbreaking Intelligent Fingerprinting Drug Screening Technology. Undertaking such a study is crucial for Intelligent Bio Solutions, as it marks a key step on their path towards venturing into the highly promising US market.Intelligent Fingerprinting Drug Screening Technology is a game-changing innovation that revolutionizes drug screening processes. By analyzing sweat from fingerprints, the technology can quickly and non-invasively detect drug compounds, providing ac...
June 12, 2024
Intelligent Bio Solutions Expands European Market Presence with Innovative Fingerprint Drug Screening Technology In a pivotal move demonstrating its burgeoning influence in the field of non-invasive drug testing, Intelligent Bio Solutions Inc. (Nasdaq: INBS) has announced a significant new addition to its roster of clients. The company has forged a relationship with a major European transport and infrastructure solutions provider, underscoring its growing footprint across the continent. This partnership will see the deployment of INBS s Intelligent Fingerprinting Drug Screening System within the United Kingdom operations of this transport leader, marking a crucial step forward in workplace drug testing and e...
February 28, 2024
In a groundbreaking collaboration, Intelligent Bio Solutions Inc. (INBS), a leading medical technology company specializing in intelligent, rapid, and non-invasive testing solutions, has joined forces with Cliantha Research, an esteemed full-service Clinical Research Organization (CRO). This partnership aims to conduct a crucial pharmacokinetic (PK) study, forming an integral part of Intelligent Bio Solutions clinical study plan for obtaining FDA 510(k) clearance. The successful completion of this study will have significant implications for the future of medical technology and exemplifies the companies commitment to revolutionizing the healthcare landscape.The Significance of the Partnership:The collabora...
January 30, 2024
The move by Robinson Brothers is indicative of a broader trend in corporates taking drug testing in-house using the non-invasive fingerprint drug testing from INBS. Companies across the spectrum have begun to recognize the quantifiable benefits of fingerprint sweat-based drug testing.The primary advantages identified by customers of this innovative system include increased in-house control, project flexibility, and productivity, not forgetting the potential for significant cost reductions. Since drug testing becomes a significantly simpler and speedier process, companies can ensure robust drug policy enforcement without compromising the flow of operations. INBS s system has been previously adopted by other c...
Publicly Traded Peers of Intelligent Bio Solutions Inc
Becton Dickinson And Company Share Performance
+22.17%
This Year
Becton Dickinson And Company
Profile
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Bluejay Diagnostics Inc follows a business model where they develop and manufacture diagnostic tests and medical devices for a variety of health conditions, aiming to provide accurate and efficient solutions to healthcare professionals and patients. They primarily operate by selling their products to hospitals, clinics, and other medical institutions.
Orasure Technologies Inc's business model revolves around the development, manufacturing, and distribution of innovative diagnostic products, primarily in the field of oral fluid diagnostics.
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
Dexcom Incs business model focuses on developing and selling continuous glucose monitoring systems for diabetes management. Their products provide real-time glucose level tracking, enabling users to better manage their condition through data-driven insights.
Sources:
Intelligent Bio Solutions Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Intelligent Bio Solutions Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
